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COMPARISON AMONG 
ARTERIAL GRAFTS AND 
CORONARY ARTERY 
An attempt at functional 
classification 
Various arterial conduits have been used for coronary artery bypass grafting. 
However, arterial grafts are not uniform either in anatomy or in function. Some 
conduits are more spastic than others and there may be possible differences in 
long-term patency rates. The diverse biologic characteristics promote a necessity of 
classification of arterial grafts, which may facilitate the understanding of surgeons 
of biologic characteristics of various arterial grafts and provide a scientific basis for 
searching for new gratis. Another important issue is the comparison of reactivity 
between arterial gratis and coronary arteries. In this study, we aim to compare the 
pharmacologic reactivity among the human arteries (gratis and coronary arteries) 
and to classify arterial gratis. Segments of three arterial gratis (gastroepiploic, 
internal mammary, and inferior epigastric) taken from patients undergoing coro- 
nary artery bypass gratiing and coronary arteries taken from explanted hearts were 
studied in organ baths for the contraction to four vasoconstrictors (endothelin-1, 
thromboxane A2 mimetic U46619, full adrenoceptor agonist norepinephrine, and 
depolarizing agent potassium) under physiologic pressure. The diameter of the four 
arteries at a pressure of 100 mm Hg was similar (p > 0.05). However, the 
gastroepiploic artery contracted to higher forces (9.41 _ 2.0 gm for endothelin, 11.79 
- 1.85 gm for U46619, 13.54 - 2.7 gm for norepinephrine, and 11.11 - 1.97 gm for 
potassium) than did the coronary artery and internal mammary artery (p < 0.05) for 
all the tested vasoconstrictors and higher than the inferior epigastric artery 
for potassium and norepinephrine (p < 0.05). There was no significant difference 
among the other three arteries (internal mammary artery, inferior epigastric artery, 
and coronary artery) regarding the maximal contraction force to any vasoconstric- 
tor. No difference was detected in regard to the sensitivity (effective concentration 
causing 50% of the maximal response) to the vasoconstrictors among the four 
arteries. This study reveals that among the arterial gratis and the coronary artery, 
the gastroepiploic artery has the highest contractility to various vasoconstrictors. 
On the basis of our findings and physiologic and embryologic knowledge we propose 
a classification for arterial grafts: type I (somatic arteries), type I I  (splanchnic 
arteries), and type I I I  (iimb arteries). Types I I  and I I I  are prone to spasm because 
of higher contractility whereas type I arteries are usually less spastic. This 
classification may have important clinical implications for the understanding of 
arterial graft spasm or patency and may be useful in the search for new gratis. (J 
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B ecause of superior long-term results of internal 
mammary artery (IMA) grafting, various arterial 
conduits have been used for coronary artery bypass 
grafting (CABG). 1-4 Such conduits include the ra- 
dial artery, 5 gastroepiploic artery (GEA), 6 inferior 
epigastric artery (IEA), 7'8 splenic artery, 9' 10 and 
subscapular arteryJ 1 However, although long-term 
patency rates for the IMA are weil established, there 
are only a few reports on other arterial conduits with 
a relatively srnall number of patients involvedJ TM It 
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is expected that other arterial conduits will have 
good long-term results as well. This kind of expec- 
tation is based on a hypothesis that all arterial 
conduits have similar biologic characteristics such 
as contractility, relaxing characteristics, endothelial 
function, and anatomic structure. However, studies 
have shown that there are differences among these 
arterial conduits regarding contractility. 15' 16 
Histologic studies have also revealed that there 
are major differences among various grafts in terms 
of structure of smooth muscle and elastic lamellaeJ 7
The differences observed from these studies uggest 
that arterial grafts, although all are arteries, are not 
uniform either in anatomy or in function. These 
differences are the anatomic and physiologic basis of 
the divergent clinical manifestations of the grafts 
and may also account for possible differences in 
long-term patency rates. One of the diverse mani- 
festations clinically observed is a different endency 
among these arterial grafts to develop spasm during 
surgical dissection and during the perioperative 
period. It is the experience of many surgeons that 
the GEA has a higher tendency to spasm than the 
IMA. TM Similarly, spasm of the radial artery is a 
serious problem that, together with a low patency 
rate that may be also related to this characteristic of
the artery, led to the abandonment of this arterial 
graft at an early stage in the 1970s. 19 Only after the 
development of a method to overcome spasm of this 
arterial graft has it recently been readopted for 
use. 2° The diverse biologic characteristics promote a
necessity for classification of arterial grafts, which 
may facilitate the understanding of surgeons of 
biologic characteristics of various arterial grafts and 
provide a scientific basis for the search for new 
grafts. 
Another important issue is the comparison be- 
tween arterial grafts and coronary arteries. There 
are obvious reasons for this. As conduits for the 
coronary artery, the grafts and the coronary artery 
form a new blood-carrying system after operation. 
Lesions at any part of this system would affect 
coronary artery flow early after operation and per- 
haps also long-term patency. Systemic administra- 
tion of drugs, in particular vasoactive agents, would 
affect both arterial grafts and coronary arteries. The 
net effect of these agents will depend on the effect of 
the agent on each part of the new system. 
In this study, we aim to classify arterial grafts by 
comparing pharmacologic reactivity of the grafts 
and to compare the function of the grafts to that of 
the human coronary artery. 
Material and methods 
Human GEA, IEA, and IMA segments were collected 
from patients undergoing CABG with use of these grafts. 
Approval to use discarded GEA, IEA, and IMA tissue was 
given by the Hospital Human Ethics Committee. Human 
coronary arteries were taken from explanted hearts of 
patients undergoing heart ransplant. After sternotomy, a 
full-length left IMA pedicle was carefully dissected from 
the chest wall. Either the left or the right IEA or the right 
GEA was harvested as a free graft. The required length 
for IMA, IEA, or GEA was carefully measured. Any 
discarded segments were collected and put into a con- 
tainer with oxygenated physiologic (Krebs) solution main- 
tained at 4 ° C and then transferred toa laboratory imme- 
diately. The IEA, GEA, and IMA were transferred into a 
glass dish and dissected out from their surrounding con- 
nective tissue. The arteries were cut into 3 mm long rings, 
and the rings were then suspended on wires in organ 
baths. 21-23 The coronary artery rings used for the pharma- 
cologic study were only taken from coronary arteries 
(large epicardial arteries) that did not show any gross 
atherosclerosis. The Krebs solution had the following 
composition (in millimoles per liter): Na + 144, K + 5.9, 
Ca 2+ 2.5, Mg 2+ 1.2, CI- 128.7, HCO 3 25, SO42- 1.2, 
H2PO 4- 1.2, and glucose 11. The solution was aerated 
with a gas mixture of 95% 02 and 5% CO2 at 37 ° _+ 0.1 ° C. 
Organ.bath technique. An organ-bath technique that 
allowed normalization of vascular ings to a physiologic 
condition in vitro was used to set the vascular ings at a 
pressure comparable to that of the in vivo situation. The 
details of the technique were published before. 21'22 
Briefly, each arterial ring was stretched in progressive 
steps to determine the individual ength-tension curve. A 
computer iterative fitting program (VESTAND by Yang- 
Hai He, Princeton, University) was used to determine the 
exponential line, the pressure and the internal diameter. 
When the transmural pressure on the rings reached 100 
mm Hg, determined from their own length-tension curves, 
the stretch procedure was stopped and the rings were then 
released to 90% of their internal circumference at 100 mm 
Hg. This degree of passive tension was then maintained 
throughout the experiment. 
We intentionally preserved the endothelium by cau- 
tiously dissecting and mounting the rings. This technique 
allowed the experiments obe done with an intact endo- 
thelium, as determined by the functional relaxation re- 
sponse to acetylcholine. TM 24 
Protocol. After the normalization procedure the vascu- 
lar rings were equilibrated for 45 minutes. The following 
protocols were designed for the experiments. 
Diameters of the IEA, GEA, IMA, and coronary artery 
at a pressure of 100 mm Hg (Dl00) and resting tensions at 
0.9 Dl00 (optimal point of the length-tension curves) 
were recorded from the normalization procedure. The 
cumulative concentration-contraction urve was randomly 
established for the following vasoconstrictor substances: 
endothelin-1; U46619, a stable thromboxane A 2 (TxA2) 
mimetic; membrane depolarizing agent potassium chlo- 
ride (K+); and norepinephrine, a full adrenoceptor ago- 
nist. Because norepinephrine induced aweak contraction 
in the coronary artery, in some coronary artery rings 
/3-adrenoceptor antagonist propranolol (1 txmol/L) was 
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Table I. Comparison of the diameter at 100 mm Hg and the resting force in various human arteries 
Coronary artery IMA IEA GEA 
(n = 24) (n = 57) (n = 24) (n = 28) p Value 
Dl00 (mm) 2.40 ± 0.12 2.04 ± 0.06 2.20 ± 0.12 2.07 ± 0.12 NS 
Resting 3.65 ± 0.26 3.20 ± 0.19 2.32 ± 0.1 1.71 ± 0.17" <0.0001 
force (gin) 
Data given as mean plus or minus standard error of mean. DIO0, Diameter at 100 mm Hg; NS, not signiflcant. 
*p < 0.01 compared with the coronary artery, IMA, or IEA (Scheffe's F test). 
Table II. Comparison of the maximal contraction and the EC»o of arterial gratis and the coronary artery to 
various vasoconstrictors 
Maximal contraction (gin) ECso (-log M) * 
P P 
CA IMA IEA GEA Value CA IMA IEA GEA Value 
ET 3.73 -+ 0.51 4.38 ± 0.54 4.88 ± 0.69 9.41 ± 2.0t:) 0.002 8.15 ± 0.13 8.22 + 0.09 8.22 ± 0.04 8.06 -+ 0.01 NS 
(n = 7) (n = 14) (n = 6) (n = 7) 
U46619 3.78 +- 0.58 6.84 ± 0.74 8.04 ± 1.23 11.79 ± 1.85t:~ 0.001 7.74 ± 0.08 8.56 ± 0.2 8.25 ± 0.09 8.44 ± 0.24 NS 
(n = 6) (n = 15) (n = 6) (n = 7) 
K ÷ 2.62 ± 0.58 5.59 ± 0.72 5.30 ± 0.87 11.11 ± 1.97t~§ 0.0006 10.21 ± 2.87 20.19 -- 1.72 14.24 ± 1.9 15.17 ± 3.5 NS 
(n = 5) (n = 15) (n = 6) (n = 7) 
NE  0.4 ± 0.31 3.75 -+ 0.51 5.13 ± 0.67 13.54 ± 2.70t~§ <0.0001 6.35 ± 1.32 5.90 ± 0.1 6.59 ± 0.18 6.36 ± 0.11 NS 
(n : 6) (n : 13) (n = 6) (n = 7) 
CA, Coronary artery; ET, endothelin; NE, norepinephrine; NS, not significant, p > 0.05 among coronary artery, IMA, and IEA in regard to endothelin, 
U46619, and norepinephrine (Scheffe's F test). 
*Concentration for K + is in millimoles per liter. 
tp < 0.05 compared with CA. 
:~p < 0.05 compared with IMA. 
§p < 0.05 compared with IEA, Scheffe's F test. 
added 30 minutes before the concentration-contraction 
curve to norepinephrine was established. 
Analysis of variance (and Scheffe's F test as post-hoc 
test) was used to compare the contraction force and 
effective concentration causing 50% of the maximal re- 
sponse (EC»o) 21' 26 for each vasoconstrictor among the 
four arteries. A value ofp < 0.05 was considered signifi- 
cant. The standard error of the mean was used throughout. 
Drugs. Drugs used in this study and their sources were 
as follows: (-)-norepinephrine bitartrate (Sigma, St. 
Louis, Mo.); U46619 (Cayman Chemical, Ann Arbor, 
Mich.); endothelin-1 (Peptides International, Louisville, 
Ky.). Stock solution of norepinephrine was freshly made 
each day. Stock solution of endothelin-1 and U46619 was 
held frozen until required. 
Results 
The number of vascular ings studied is listed in 
Table I, which also lists the diameter and the passive 
resting force for the arterial conduits and for the 
coronary artery. The diameter of the four arteries at 
a pressure of 100 mm Hg was similar (p > 0.05). 
However, the resting force for the GEA was signif- 
icantly lower than that for other vessels and this 
reflects the different compliance of this artery com- 
pared with that of others. 
Table II gives the maximal contraction force and 
the EC»0 values for endothelin, U46619, K +, and 
norepinephrine in the four arteries. There was a 
significant difference among the four arteries for all 
these four vasoconstrictors regarding the maximal 
contraction. In particular, the GEA contracted with 
all the vasoconstrictors tested to higher forces than 
those measured in the coronary artery and the IMA 
(p < 0.05, Scheffe's F test) and also higher than 
those in the IEA for potassium and norepinephrine 
(p < 0.05, Scheffe's F test). There was no significant 
difference among the other three arteries (IMA, 
IEA, and coronary artery) regarding the maximal 
contraction force to either vasoconstrictor. In regard 
to EC»0 , there was no difference detected (p > 0.05) 
among the four arteries. The average concentration- 
contraction curves for these vasoconstrictors are 
shown in Figs. 1 through 4. Figure 4 also demon- 
strates that when /3-adrenoceptor function is 
blocked by propranolol (1 /zmol/L), the coronary 
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Fig. 1. Mean concentration (-log M)-contraction 
(force) curves for endothelin-1 (endothelin), in GEA, 
IEA, IMA, and coronary artery (CA). Symbols represent 
data averaged from at least six rings for each vessel (see 
Table II for number of rings). Vertical bars are 1 standard 
error of mean. 
artery contracts with norepinephrine to a signifi- 
cantly higher level (Fig. 4, b). 
Diseussion 
Although comparisons between the IEA and IMA 
and between the GEA and IMA have been made, 
the results are contradictory. Dignan and associ- 
ates 1» have found that the GEA is more reactive 
to K +, norepinephrine, and 5-hydroxytryptamine, 
whereas others have suggested that the GEA and 
IMA have similar responses to norepinephrine, z7 
phenylephrine, and 5-hydroxytryptamine 2s and that 
the IMA is more reactive to TxA a mimetic 
U46619. 27 The diverse results from different groups 
may reflect the variation of technology used in the 
studies. In fact, results of in vitro pharmacologic 
studies of blood vessels at large depend on the 
set-up condition of the vessels. For example, at 
various resting forces, the vessel may have different 
reactions to vasoactive substances. Therefore to set 
the vessels at an optimal point of its own length- 
tension exponential curve may mimic the in vivo 
pressure and make a comparative basis for different 
vessels.21, 22 From this point of view, to compare the 
pharmacologic reactivity of various arterial conduits 
in one laboratory has a particular advantage and 
accuracy. With such a basis, the functional compar- 
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Fig. 2. Mean concentration (-log M)-contraction 
(force) curves for TxA 2 (U46619) in GEA, IEA, IMA, and 
coronary artery (CA). Symbols represent data averaged 
from at least six rings for each vessel (see Table II for 
number of rings). Vertical bars are 1 standard error of 
mean. 
ison and classification of grafts are attempted in our 
present study. 
The present study, because of the technology 
used, also provides information on vascular diame- 
ter at a comparable basis. Judgment of the diameter 
of arterial grafts could be difficult because this 
parameter at large depends on intramural pressure. 
The diameter measured at zero pressure, as in 
autopsy, is different flora that in the in vivo situa- 
tion. Similarly, even at in vivo status the diameter is 
changeable with the pressure change in a certain 
fange. Therefore without pressure measurement the 
measurement of the diameter does not provide valid 
information. With use of a special technology 21-25 
that allows measurement of the individual ength- 
tension (diameter-pressure) curve, we are able to 
compare the diameter of the arterial grafts and 
coronary arteries at a comparable basis, that is, at a 
pressure of 100 mm Hg. From the present study, the 
average diameter of these vessels at 100 mm Hg was 
2.04 mm for IMA, 2.2 mm for IEA, 2.07 mm for 
GEA, and 2.4 mm for coronary artery (p > 0.05, 
Table I). These measurements demonstrate suitabil- 
ity of various arterial grafts as conduits for the 
coronary artery as far as the size is concerned. 
In previous tudies, although numerous vasocon- 
strictors have been used to investigate the reactivity 
of the grafts, the reactivity of various arterial grafts 
to endothelin has not been compared. Endothelin 
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Fig. 3. Mean concentration (-log M)-contraction (force) curves for potassium chloride (K) in GEA, 
IEA, IMA, and coronary artery (CA). Symbols represent data averaged from at least five rings for each 
vessel (see Table II for number of rings). Vertical bars are 1 standard error of mean. 
has been proposed as the most potent vasoconstric- 
tor known. 29 An elevated plasma level of endothelin 
has been measured uring cardiopulmonary b - 
pass. 3° Therefore this vasoconstrictor may have a 
pathogenic significance invasospasm related to car- 
diac operation. Other vasoconstrictors tested in the 
present study were U46619, norepinephrine, and 
K +. Norepinephrine was selected for the present 
study because it is a full adrenoceptor agonist and 
an important neurotransmitter. Its effect on the 
human IMA has been extensively studied. 22-2s' 31-34 
The TxA 2 mimetic U46619 was used in this study 
because this vasoconstrictor, derived from platelets, 
is a potent agonist in the IMA and IEA. An elevated 
plasma level of TxA 2 during cardiopulmonary b - 
pass, similar to endothelin, has been found. 35' 36 In 
addition, the cellular membrane depolarizing agent 
potassium ion (K +) was also used to study contrac- 
tility. 
The reactivity of various blood vessels is different. 
In a previous study, 21 we have demonstrated a 
divergence of pharmacologic reactivity among the 
canine IMA, the saphenous vein, and the coronary 
artery. In general, saphenous veins and coronary 
arteries are more reactive compared with the IMA. 
However, such a comparison regarding reactivity 
has not yet been made in human vessels. One of the 
major aims of the present study, therefore, was to 
compare and classify arterial grafts according to 
their reactivity. Our results demonstrate that among 
the four arteries (three arterial grafts and the coro- 
nary artery) the GEA is the most reactive artery. 
This is shown by the fact that this artery is the most 
reactive one in response to all the four vasoconstric- 
tor substances tested. The maximal contraction 
force to these vasoconstrictors was 9.41 gm for 
endothelin, 11.79 gm for U46619, 11.11 gm for K +, 
and 13.54 gm for norepinephrine. Because the 
length of the vascular segment was 3 mm for each 
artery, these contraction forces reflect tension de- 
veloped by each unit of vascular segment and are 
comparable among the arteries. Out results regard- 
ing contractility oTxA 2 are different from those of 
others. O'Neil and associates 27 has found that the 
IMA is more reactive to TxA 2 than the GEA is. 
Conversely, inthe present study, we have found that 
although TxA 2 is a potent vasoconstrictor in all the 
four arteries, it produced the highest force in the 
GEA, as did the other three vasoconstrictors. This 
uniform characteristic of the GEA clearly demon- 
strates that this artery is the most reactive artery 
among the arteries tested. This is in accordance with 
our clinical observations and those of others la that 
the GEA is prone to vasospasm during surgical 
dissection. 
Other arteries, that is, the IEA, the IMA, and the 
coronary artery, are similar regarding the maximal 
contraction to endothelin, U46619, or K + (p > 
0.05). In regard to norepinephrine, the contraction 
force of coronary arteries is slightly (p > 0.05, 
Scheffe's F test; Table II) less than that of the IMA 
or IEA. However, this does not simply mean that 
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Fig. 4. a, Mean concentration (-log M)-contraction (force) curves for norepinephrine in GEA, IEA, 
IMA, and coronary artery (CA). b, Comparison of contraction curves for coronary artery with (n = 6) or 
without (n = 4) /3-adrenoceptor antagonist propranolol (1 /zmol/L). Coronary artery incubated with 
propranolol for 30 minutes had significantly higher contraction (p < 0.05, unpaired t test on maximum 
contraction). Symbols represent data averaged from group of vessel (see Table II for number of rings in 
each group). Vertical bars are 1 standard error of mean. 
coronary arteries are less reactive to norepineph- 
rine. Norepinephrine is a full agonist for adrenocep- 
tors, which have ~ and/3 types. It is well known that 
the smooth muscle of coronary arteries contains 
both receptors and that o~-adrenoceptors mediate 
contraction whereas/3-adrenoceptors mediate relax- 
ation. Norepinephrine stimulates both o~- and/3-ad- 
renoceptors in coronary arteries and therefore the 
net effect is little contraction. When the 13-adreno- 
ceptor is blocked the «-adrenoceptor-mediated 
contraction will be unmasked. This has been dem- 
onstrated by previous studies 37 and also by the 
present study. Fig. 4, b demonstrates that when the 
human coronary artery is incubated with the/3-ad- 
renoceptor antagonist propranolol (1 ixmol/L) the 
«-adrenoceptor-mediated contraction is unmasked. 
Therefore contraction force to norepinephrine is
markedly enhanced. In contrast, the human IMA is 
an artery with predominant ~-adrenoceptors. 24 
From the similar reaction of the IEA to norepineph- 
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rine, and even more enhanced contraction in the 
GEA, we may suspect hat these two arteries are 
also a-adrenoceptor predominant and may also 
have weak function of/3-adrenoceptors. However, 
this is to be studied. 
As mentioned previously, coronary arteries are 
highly reactive vessels as demonstrated in the dog. 21 
In the present study, we could not demonstrate hat 
the human coronary artery was more reactive than 
other arteries uch as the IMA or IEA. In fact, in 
our experiments there was a tendency that the 
reactivity of the human coronary artery was lower 
than that of other arteries. This may be partially 
because the explanted hearts, from which the coro- 
nary arteries were taken, were from patients under- 
going heart transplant. The cause of the heart 
disease was disregarded, and some of those patients 
had coronary artery disease. Although the speci- 
mens were taken from the coronary arteries without 
obvious atherosclerosis, these arteries could have 
had pathologic hanges that might reduce the reac- 
tivity. 
The results from the present study may be used to 
classify arterial grafts. From anatomic consider- 
ations, other splanchnic (visceral) arteries, such as 
the splenic artery, may be similar to the GEA 
although no data are available yet. Somatic arteries 
located in the body wall such as the subscapular 
artery or the intercostal artery may be similar to the 
IMA. As already demonstrated, the IEA is similar to 
the IMA as far as contractility is concerned, 38and 
both are somatic arteries. As for the radial artery, 
this artery is located in the distal part of the arm and 
therefore is more spastic, as arteries at the extrem- 
ities are usually prone to spasm (as seen in 
Raynaud's disease). On the basis of these anatomic 
considerations and the results of our present study, 
we propose a classification for arterial grafts (Table 
III). This classification suggests that there are three 
types of arterial grafts. Type I is composed of 
somatic arteries, whereas type II are splanchnic 
arteries and type III are limb arteries. Type II 
arteries are prone to spasm because of the higher 
contractility of splanchnic arteries. This characteris- 
tic of splanchnic arteries has a physiologic meaning 
that blood flow through splanchnic arteries is sub- 
ject to tremendous changes under various circum- 
stances in accord with the function of the alimentary 
tract. The flow increases after meals and decreases 
under critical situations. In contrast, type I arterial 
grafts (somatic arteries) are less reactive than type II 
grafts because they are mainly conduit arteries 
except at the end of the artery, which is a muscular 
Table III. Functional classification of arterial gratis 
on the basis of contractility; the contractility of the 
coronary artery is also compared 
Type I Type II Type III 
(somatic (splanchnic (limb 
arteries ) * arteries ) t arteries ) 
Radial Coronary 
IMA IEA GEA artery artery¢ 
ET +++ +++ ++++ § +++ 
U46619 +++ +++ ++++ +++ +++ 
NE +++ +++ ++++ +++ +++11 
KG1 +++ +++ ++++ ++++ +++ 
Grade from + to + + + + (+ is the least). Both the maximal contraction (+ 
to + + +) and ECso (+) are taken into account. The grade is based on the 
present study except hat for radial artery (from reference 16). In general, 
the contractility is on the order of splanchnic arteries > limb arteries -> 
coronary arteries >- somatic arteries. ET, Endothelin; NE, norepinephrine. 
*Intercostal rteries and subscapular teries may also belong to the type 
I group because of anatomic and embryologic onsiderations, although 
there are no pharmacologic data available. 
tBecause of anatomic and embryologic onsiderations, splenic arteries 
may belong to the type II group. However, no data on the eontractility of
these arteries are available, and this is still speculative. 
~:Coronary artery contracts with norepinephrine to a low force becanse this 
artery has strong/3-adrenergic function (see Fig. 4, b). 
§No data available. 
HThe reactivity of eoronary artery in the present study may be underesti- 
mated beeanse the arteries taken from explanted hearts may have coronary 
disease that could reduce the reactivity. In our eanine experiments, 
coronary artery is highly reactive to K + and U46619. 21 
regulator for blood flow, as recently demonstrated 
in the human IMA. 32-34 Type III arteries are located 
in limbs, represented by the radial artery, and have 
higher tendency for spasm compared with somatic 
arteries (type I). 
Although our classification is based on pharma- 
cologic studies and anatomic onsiderations, there is 
evidence that it is in accordance with embryologic 
factors. 39 From embryologic considerations, somatic 
arteries are intersegmental branches to the body 
wall. These arteries persist in the thoracic and 
lumbar regions as the posterior intercostal, subcos- 
tal, and lumbar arteries. Near the anterior median 
line intersegmental rteries are linked by a ventral 
somatic anastomosis. These vessels persist bilater- 
ally as the internal mammary artery and the superior 
and inferior epigastric arteries. In our classification, 
these are the type I arteries. In contrast, type II 
arteries (splanchnic arteries) are from segmental 
branches of primitive dorsal aorta to supply the 
digestive tube. The dorsal splanchnic anastomosis 
persists in the GEA. The arteries of the upper limbs 
(type III in our classification), such as the radial 
artery, are also developed from intersegmental r- 
teries as somatic arteries, although the arteries of 
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the lower limb arise from the dorsal root of the 
umbilical artery. 
This classification may have an implication in 
regard to the search for new arterial gratis. As far as 
vasospasm is concerned, type I arteries may be less 
spastic than type II and type III arteries. The IMA is 
a typical example of a type I artery. Although the 
IMA is also a reactive artery, vasospasm is encoun- 
tered less in this artery than in type II or type III 
arteries. This is true in particular when its most 
reactive portion, the distal section, is trimmed 
off.32, 40 The less spastic haracteristics are obviously 
advantageous perioperatively. In fact, in common 
clinical practice today, the IMA is used as the first 
choice of arterial grafts. In general, the correlation 
between contractility and long-term patency is still 
unclear. Other factors, particularly the structure of 
the endothelium, may also contribute to long-term 
patency. A recent report on the long-term patency 
rates of the GEA suggests an equal patency rate for 
this arterial graft to that for the IMA, TM although the 
follow-up was not as long as that for the IMA. At the 
least it is clear that higher contractility of arterial 
grafts, which means a tendency to reduce the diam- 
eter of the artery, is a disadvantage for the mainte- 
nance of coronary artery flow perioperatively and 
may necessitate pharmacologic treatment. 
The reason to classify arterial grafts on the basis 
of contractility rather than on the basis of relaxation 
is that although vascular eactivity is composed of 
contractility and relaxation, the latter depends on 
the contractility. Relaxation occurs only in an artery 
that is already contracted and therefore is secondary 
to existing contraction. Although various vasodila- 
tors may have different relaxing effects on arterial 
grafts and one particular vasodilator may also have 
different effects on different arteries, these differ- 
ences are offen vasoconstrictor dependent, hat is, 
contraction dependent. 23'25'31 Therefore we have 
attempted to classify the arterial grafts on the basis 
of reactivity to vasoconstrictors (contractility) rather 
than on the basis of relaxation. 
In the present study, no attempt was made to 
compare arterial grafts or coronary arteries with 
venous gratis because it is weil known that there are 
marked differences between arterial and venous 
grafts regarding contractility 41 and long-term paten- 
cy, TM 
In summary, the present study reveals that among 
the arterial gratis and the coronary artery, the GEA 
has the highest contractility to various vasoconstric- 
tors. On the basis of our findings and the anatomic, 
embryologic, and physiologic knowledge we have 
proposed a classification for arterial gratis: type I 
(somatic arteries), type II (splanchnic arteries), and 
type III (limb arteries). Types II and III are prone to 
spasm because of higher contractility whereas type I
arteries are usually less spastic. This classification 
may have important clinical implications for the 
understanding of arterial graft spasm or patency and 
may be useful in the search for new grafts. 
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